📜3-氰基苯酚置于sodium Nitrite Sodium Nitrate,硫酸体系中,用 二氯甲烷 用作溶剂,以28%的收率获得3-羟基-4-硝基苯甲腈
参考文献:Il-8 Receptor Antagonists
标题:Il-8 Receptor Antagonists
摘要:这项发明涉及新化合物和苯基脲在治疗由趋化因子白细胞介素-8(il-8)介导的疾病状态中的新用途.具体而言,这项发明涉及式(ia)的新化合物及其在治疗趋化因子介导疾病中的用途,其中趋化因子结合到il-8的a或b受体.式(ia)的化合物由以下结构表示:##str1## 其中,X是氧或硫;Rb是nr.Sub.6 R.Sub.7,Alkcyl,Aryl,Arylc.Sub.1-4 Alkyl,Aryl C.Sub.2-4 Alkenyl,Heteroaryl,Heteroarylc.Sub.1-4 Alkyl,Heteroarylc.Sub.2-4 Alkenyl,Heterocyclic或heterocyclic C.Sub.1-4 Alkyl,或者是一个heterocyclic C.Sub.2-4 Alkenyl基团,均可选择性地被取代;R.Sub.1是独立选择自氢;卤素;硝基;氰基;C.Sub.1-10 Alkyl;卤代c.Sub.1-10 Alkyl;C.Sub.2-10 Alkoxy;卤代c.Sub.1-10 Alkoxy;叠氮基;(Cr.Sub.8 R.Sub.8)Q S(O).Sub.T R.Sub.4;羟基;羟基取代的c.Sub.1-4 Alkyl;Aryl;Aryl C.Sub.1-4 Alkyl;Aryl C.Sub.2-10 Alkenyl;Aryloxy;Aryl C.Sub.1-4 Alkyloxy;Heteroaryl;Heteroarylalkyl;Heteroaryl C.Sub.2-10 Alkenyl;Heteroaryl C.Sub.1-4 Alkyloxy;Heterocyclic;Heterocyclic C.Sub.1-4 Alkyl;Heterocyclicc.Sub.1-4 Alkyloxy;Heterocyclic C.Sub.2-10 Alkenyl;Q为0或具有1至10的值的整数;N为具有1至3的值的整数;M为具有1至3的值的整数;Y为氢;卤素;硝基;氰基;卤代c.Sub.1-10 Alkyl;C.Sub.1-10 Alkyl;C.Sub.2-10 Alkenyl C.Sub.1-10 Alkoxy;卤代c.Sub.1-10 Alkoxy;叠氮基;(Cr.Sub.8 R.Sub.8)Qs(O).Sub.T R.Sub.4,(Cr.Sub.8 R.Sub.8)Qor.Sub.4;羟基;羟基取代的c.Sub.1-4 Alkyl;Aryl;Aryl C.Sub.1-4 Alkyl;Aryloxy;Arylc.Sub.1-4 Alkyloxy;Aryl C.Sub.2-10 Alkenyl;Heteroaryl;Heteroarylalkyl;Heteroaryl C.Sub.1-4 Alkyloxy;Heteroaryl C.Sub.2-10 Alkenyl;Heterocyclic,Heterocyclic C.Sub.1-4 Alkyl;Heterocyclicc.Sub.2-10 Alkenyl;或其药学上可接受的盐.